权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Recognition of Viral DNA by APOBEC3 Proteins and their Antagonization by HIV Vif

APOBEC3 蛋白对病毒 DNA 的识别及其 HIV Vif 的拮抗作用

基本信息

批准号：
9079350
负责人：
Yong Xiong
金额：
$ 41.48万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-06-15 至 2020-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9079350
关键词：
APOCEC3G gene Acquired Immunodeficiency Syndrome Affinity Antiviral Agents Binding Biochemical Biochemistry Biological Assay Biophysics C-terminal Catalytic Domain Cells Chimeric Proteins Communities Comorbidity Complement Complex Cytidine Deaminase DNA DNA Sequence DNA-Protein Interaction Deaminase Electron Microscopy Fluorescence Genome Goals HIV HIV Infections HIV-1 Health Host Defense Host Defense Mechanism Human Immune Immune system Infection Knowledge Length Malignant Neoplasms Maps Mediating Methods Molecular Mutagenesis Mutate Pathway interactions Positioning Attribute Protein Engineering Protein Family Proteins Recruitment Activity Research Research Project Grants Reverse Transcription Solubility Spectrum Analysis Structure System Therapeutic Viral Viral Genome Viral Proteins Virion Virus Inhibitors Work X-Ray Crystallography antiretroviral therapy base combat design enzyme mechanism inhibitor/antagonist innovation multicatalytic endopeptidase complex novel pathogen preference prevent structural biology success three dimensional structure tool ubiquitin-protein ligase viral DNA

项目摘要

DESCRIPTION (provided by applicant): The host immune system has diverse defenses that combat viral invasions, such as infection by human immunodeficiency virus type 1 (HIV-1), which causes acquired immunodeficiency syndrome (AIDS) and major comorbidities such as cancer. The human antiviral proteins APOBEC3G (A3G) and APOBEC3F (A3F) are cellular cytidine deaminases that suppress HIV infection by hypermutation of viral genome and physically blocking reverse transcription, which prevents the accumulation of HIV-1 DNA. To evade this host defense mechanism, HIV expresses the virion infectivity factor (Vif), which hijacks a cellular E3 ubiquitin ligase complex to target A3F/G for proteasome-mediated degradation. Despite intense research and progress in the structure elucidation of a Vif-containing E3 ubiquitin ligase complex, the mechanisms by which APOBEC3 (A3) proteins select specific viral DNA sequences and the molecular interactions employed by Vif to recognize A3 proteins remain unclear. Our overall goal is to establish the biochemical and structural principles by which A3 proteins mutate viral DNA and HIV-1 Vif sequesters the A3 proteins. To achieve this goal, we will use a combination of biochemistry, biophysics, structural biology, and cell-based functional assays to dissect the interactions between different A3 proteins and substrate DNAs, interrogate the assembly of the Vif/E3 ligase/A3 complex, and obtain detailed three-dimensional structural information of these interaction complexes. We have devised innovative strategies to capture structures of multiple A3 proteins in complex with their preferred DNA substrates. These results will provide essential information to help decipher the DNA recognition and sequence preference mechanisms of these enzymes. We will further delineate the structural details of Vif-A3 protein interactions by constructing rationally designed structural targets that represent the molecular interfaces. We will also investigate the substrate assembly pathway using spectroscopy methods and determine the structure of the completely assembled molecular complex containing A3, Vif and the E3 ubiquitin ligase. The success of the proposed work will significantly advance our understanding of an important host immune defense system against HIV and viral evasion strategy. Information obtained will facilitate the design of Vif inhibitors as a novel class of antiretroviral therapy to complement the existing armamentarium.